U.S. Top Stock Picks from Analysts

Strategy

Market Cap: US$93.9b

Operates as a bitcoin treasury company in the United States, Europe, the Middle East, Africa, and internationally.

Atlassian

Market Cap: US$44.8b

Provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.

Charter Communications

Market Cap: US$40.0b

Operates as a broadband connectivity and cable operator company serving residential and commercial customers in the United States.

Circle Internet Group

Market Cap: US$27.4b

Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.

QXO

Market Cap: US$13.8b

Distributes roofing, waterproofing, and other building products in the United States.

Duolingo

Market Cap: US$12.9b

Operates as a mobile learning platform in the United States, the United Kingdom, and internationally.

BioMarin Pharmaceutical

Market Cap: US$11.3b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Aurora Innovation

Market Cap: US$10.4b

Operates as a self-driving technology company in the United States.

U-Haul Holding

Market Cap: US$10.2b

Operates as a do-it-yourself moving and storage operator for household and commercial goods in the United States and Canada.

monday.com

Market Cap: US$9.5b

Develops software applications in the United States, Europe, the Middle East, Africa, the United Kingdom, and internationally.

Moderna

Market Cap: US$9.4b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Galaxy Digital

Market Cap: US$9.2b

Engages in the digital asset and data center infrastructure businesses.

Chime Financial

Market Cap: US$9.0b

A financial technology company, provides digital consumer banking and payment solutions.

Liberty Broadband

Market Cap: US$8.6b

Engages in a range of communications businesses in the United States.

VinFast Auto

Market Cap: US$8.0b

Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.

Corcept Therapeutics

Market Cap: US$7.5b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Revolution Medicines

Market Cap: US$7.4b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Legend Biotech

Market Cap: US$6.6b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Clearwater Analytics Holdings

Market Cap: US$6.1b

Develops and provides a Software-as-a-Service (SaaS) solution for automated investment data aggregation, reconciliation, accounting, and reporting services to insurers, investment managers, corporations, institutional investors, and government entities in the United States and internationally.

Cytokinetics

Market Cap: US$6.0b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

MARA Holdings

Market Cap: US$5.9b

Operates as a digital asset technology company in the United States and Europe.

Caesars Entertainment

Market Cap: US$5.2b

Operates as a gaming and hospitality company.

CRISPR Therapeutics

Market Cap: US$4.8b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Bruker

Market Cap: US$4.5b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

Vaxcyte

Market Cap: US$4.2b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

ADMA Biologics

Market Cap: US$4.0b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Vertex

Market Cap: US$4.0b

Provides enterprise tax technology solutions for retail trade, wholesale trade, and manufacturing industries in the United States and internationally.

Arcellx

Market Cap: US$3.9b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

Qfin Holdings

Market Cap: US$3.9b

Qfin Holdings, Inc., together with its subsidiaries, operate AI- driven credit-tech platform under the Qifu Jietiao brand in the People’s Republic of China.

Arrowhead Pharmaceuticals

Market Cap: US$3.8b

Develops medicines for the treatment of intractable diseases in the United States.

Globalstar

Market Cap: US$3.8b

Provides mobile satellite services in the United States, Canada, Europe, Central and South America, and internationally.

Freshworks

Market Cap: US$3.8b

A software development company, provides software-as-a-service products in North America, Europe, the Middle East, Africa, Asia Pacific, and internationally.

Lantheus Holdings

Market Cap: US$3.7b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

Metsera

Market Cap: US$3.7b

A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.

Zai Lab

Market Cap: US$3.7b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Akero Therapeutics

Market Cap: US$3.6b

Engages in the development of treatments for patients with serious metabolic diseases in the United States.